Nanda Approved Diagnoses
Nanda Approved Diagnoses - Related Videos
01:26
FDA Approved Drugs: Changes to Approved Drugs
0 Views •
2025
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
05:05
Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
0 Views •
Cited by 95 •
2011
We describe a technique for labeling and tracking stem cells with FDA-approved, superparamagnetic iron oxide (SPIO), ferumoxytol (Feraheme). This cellular imaging technique that utilizes magnetic resonance (MR) imaging for visualization, is readily accessible for long-term monitoring and diagnosis of successful or unsuccessful stem cell engraftments in patients.
01:24
Diagnosing Acidosis and Alkalosis
0 Views •
2024
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature. First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis). Next, the PCO2 and HCO3− values are examined to...
10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
0 Views •
Cited by 24 •
2013
Rescue of recombinant arenaviruses from cloned cDNAs, an approach referred to as reverse genetics, allows researchers to investigate the role of specific viral gene products, as well as the contribution of their different specific domains and residues, to many different aspects of the biology of arenavirus. Likewise, reverse genetics techniques in FDA-approved cell lines (Vero) for vaccine development provides novel possibilities for the generation of effective and safe vaccines to combat human...
10:29
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
0 Views •
Cited by 83 •
2010
In this article, we examine the methodology and considerations relevant to the FDA approved depression treatment protocol using the Neuronetics NeuroStar TMS device.
FAQs
A NANDA-approved diagnosis describes a patient response, health-related vulnerability, or life-process concern that nursing can assess and address. A medical diagnosis identifies a disease or disorder. This distinction keeps nursing judgments focused on patient-specific needs and helps nurses select care actions based on assessment findings rather than simply repeating the patient’s medical condition.
Nurses compare assessment findings with the recognized diagnostic label and examine whether the available information supports its defining characteristics, related factors, or risk factors. This matching process connects observed patient responses with a standardized nursing judgment. It also encourages nurses to base decisions on documented evidence instead of choosing a label without a clear assessment rationale.
Related factors help explain conditions associated with an identified patient response, while risk factors support recognition of vulnerability to a potential problem. Considering these elements gives the diagnosis more clinical specificity and helps shape an individualized care plan. The resulting plan can address the patient’s situation directly and provide a clearer basis for evaluating change over time.
They organize assessment information into nursing-specific concerns that can be compared when planning care. By identifying the patient responses or vulnerabilities requiring attention, nurses can establish priorities and connect them with individualized interventions and measurable outcomes. This approach helps the care plan remain focused on clinically relevant needs rather than becoming a list of unrelated observations.
The workflow begins with patient assessment, followed by analysis of the findings and comparison with a recognized NANDA-I label. The nurse then uses the supported diagnosis to guide individualized interventions and define measurable outcomes. During follow-up, documentation of the patient’s response allows the nurse to evaluate care and determine whether the plan remains appropriate.
Standardized diagnostic labels give nurses and other team members a shared way to describe nursing-relevant patient concerns. Because the labels connect assessment findings with planned care, they make documentation and handoffs more consistent. This common language supports coordinated discussion of priorities, interventions, and outcomes without substituting a disease name for the patient response being addressed.
Evaluation depends on comparing documented patient responses with the measurable outcomes established in the care plan. If findings change, the nurse can judge whether interventions are producing the intended result and revise the plan when needed. This links the original assessment to an observable outcome, making nursing decisions easier to review and communicate.
A shared diagnostic language helps education programs teach students how to connect assessment findings with nursing decisions and care planning. In research, standardized labels provide consistent terms for examining patient responses, interventions, and outcomes. Their use strengthens comparisons across clinical documentation and supports clearer communication of nursing knowledge without reducing care to medical disease categories.